FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283369614> ?p ?o ?g. }

• W4283369614 abstract "The use of therapeutic neutralizing antibodies against SARS-CoV-2 infection has been highly effective. However, there remain few practical antibodies against viruses that are acquiring mutations. In this study, we created 494 monoclonal antibodies from COVID-19-convalescent patients, and identified antibodies that exhibited comparable neutralizing ability to clinically used antibodies in the neutralization assay using pseudovirus and authentic virus including variants of concerns. These antibodies have different profiles against various mutations, which were confirmed by cell-based assay and cryo-electron microscopy. To prevent antibody-dependent enhancement, N297A modification was introduced, and showed a reduction of lung viral RNAs by therapeutic administration in a hamster model. In addition, an antibody cocktail consisting of three antibodies was also administered therapeutically to a macaque model, which resulted in reduced viral titers of swabs and lungs and reduced lung tissue damage scores. These results showed that our antibodies have sufficient antiviral activity as therapeutic candidates." @default.
• W4283369614 created "2022-06-25" @default.
• W4283369614 creator A5002226169 @default.
• W4283369614 creator A5007726405 @default.
• W4283369614 creator A5009833598 @default.
• W4283369614 creator A5017723864 @default.
• W4283369614 creator A5021997473 @default.
• W4283369614 creator A5022504627 @default.
• W4283369614 creator A5024546378 @default.
• W4283369614 creator A5026668985 @default.
• W4283369614 creator A5029676343 @default.
• W4283369614 creator A5029833592 @default.
• W4283369614 creator A5035608341 @default.
• W4283369614 creator A5037160876 @default.
• W4283369614 creator A5039137137 @default.
• W4283369614 creator A5046561002 @default.
• W4283369614 creator A5047228575 @default.
• W4283369614 creator A5048037771 @default.
• W4283369614 creator A5061740993 @default.
• W4283369614 creator A5062280488 @default.
• W4283369614 creator A5063207159 @default.
• W4283369614 creator A5063515948 @default.
• W4283369614 creator A5066012827 @default.
• W4283369614 creator A5066612748 @default.
• W4283369614 creator A5072409367 @default.
• W4283369614 creator A5073381036 @default.
• W4283369614 creator A5076363097 @default.
• W4283369614 creator A5076456351 @default.
• W4283369614 creator A5077688766 @default.
• W4283369614 creator A5078140536 @default.
• W4283369614 creator A5078790167 @default.
• W4283369614 creator A5083314956 @default.
• W4283369614 creator A5084564678 @default.
• W4283369614 date "2022-06-22" @default.
• W4283369614 modified "2023-10-18" @default.
• W4283369614 title "Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models." @default.
• W4283369614 doi "https://doi.org/10.1101/2022.06.21.496751" @default.
• W4283369614 hasPublicationYear "2022" @default.
• W4283369614 type Work @default.
• W4283369614 citedByCount "0" @default.
• W4283369614 crossrefType "posted-content" @default.
• W4283369614 hasAuthorship W4283369614A5002226169 @default.
• W4283369614 hasAuthorship W4283369614A5007726405 @default.
• W4283369614 hasAuthorship W4283369614A5009833598 @default.
• W4283369614 hasAuthorship W4283369614A5017723864 @default.
• W4283369614 hasAuthorship W4283369614A5021997473 @default.
• W4283369614 hasAuthorship W4283369614A5022504627 @default.
• W4283369614 hasAuthorship W4283369614A5024546378 @default.
• W4283369614 hasAuthorship W4283369614A5026668985 @default.
• W4283369614 hasAuthorship W4283369614A5029676343 @default.
• W4283369614 hasAuthorship W4283369614A5029833592 @default.
• W4283369614 hasAuthorship W4283369614A5035608341 @default.
• W4283369614 hasAuthorship W4283369614A5037160876 @default.
• W4283369614 hasAuthorship W4283369614A5039137137 @default.
• W4283369614 hasAuthorship W4283369614A5046561002 @default.
• W4283369614 hasAuthorship W4283369614A5047228575 @default.
• W4283369614 hasAuthorship W4283369614A5048037771 @default.
• W4283369614 hasAuthorship W4283369614A5061740993 @default.
• W4283369614 hasAuthorship W4283369614A5062280488 @default.
• W4283369614 hasAuthorship W4283369614A5063207159 @default.
• W4283369614 hasAuthorship W4283369614A5063515948 @default.
• W4283369614 hasAuthorship W4283369614A5066012827 @default.
• W4283369614 hasAuthorship W4283369614A5066612748 @default.
• W4283369614 hasAuthorship W4283369614A5072409367 @default.
• W4283369614 hasAuthorship W4283369614A5073381036 @default.
• W4283369614 hasAuthorship W4283369614A5076363097 @default.
• W4283369614 hasAuthorship W4283369614A5076456351 @default.
• W4283369614 hasAuthorship W4283369614A5077688766 @default.
• W4283369614 hasAuthorship W4283369614A5078140536 @default.
• W4283369614 hasAuthorship W4283369614A5078790167 @default.
• W4283369614 hasAuthorship W4283369614A5083314956 @default.
• W4283369614 hasAuthorship W4283369614A5084564678 @default.
• W4283369614 hasBestOaLocation W42833696141 @default.
• W4283369614 hasConcept C14086860 @default.
• W4283369614 hasConcept C142724271 @default.
• W4283369614 hasConcept C159047783 @default.
• W4283369614 hasConcept C159654299 @default.
• W4283369614 hasConcept C203014093 @default.
• W4283369614 hasConcept C2522874641 @default.
• W4283369614 hasConcept C2779134260 @default.
• W4283369614 hasConcept C2779261636 @default.
• W4283369614 hasConcept C3007834351 @default.
• W4283369614 hasConcept C3008058167 @default.
• W4283369614 hasConcept C32611913 @default.
• W4283369614 hasConcept C524204448 @default.
• W4283369614 hasConcept C542903549 @default.
• W4283369614 hasConcept C71924100 @default.
• W4283369614 hasConcept C86803240 @default.
• W4283369614 hasConceptScore W4283369614C14086860 @default.
• W4283369614 hasConceptScore W4283369614C142724271 @default.
• W4283369614 hasConceptScore W4283369614C159047783 @default.
• W4283369614 hasConceptScore W4283369614C159654299 @default.
• W4283369614 hasConceptScore W4283369614C203014093 @default.
• W4283369614 hasConceptScore W4283369614C2522874641 @default.
• W4283369614 hasConceptScore W4283369614C2779134260 @default.
• W4283369614 hasConceptScore W4283369614C2779261636 @default.
• W4283369614 hasConceptScore W4283369614C3007834351 @default.
• W4283369614 hasConceptScore W4283369614C3008058167 @default.
• W4283369614 hasConceptScore W4283369614C32611913 @default.
• W4283369614 hasConceptScore W4283369614C524204448 @default.

• next